This is from mystoxsuck on IV board. Thought it might be appreciated here.....
Everytime that I think the tide has turned...
...this stock sinks like a rock. Will February 1 begin the change? If no results come before March, will March 1 begin the turn? Will it ever turn? How can the short interest still rise at this point? Lots of questions, but no answers. Perhaps, short hedge funds who have been burned on other RJ Kirk stocks are piling on, hoping to finally make a big score. The delay in results is undoubtedly due to insufficient events/deaths to trigger a halt, and it has to be due to Pali. The proposition put forth by some analysts that doxi may be outperforming pali is ludicrous. Doxi is the control; its efficacy is well-known in sarcoma, and no surprises are to be had. If doxi were outperforming pali, then the trial would have been halted for futility, because the trial is studying pali, not doxi, and patients on the pali arm would ethically have to be switched to doxi alone.
This one is a real puzzle to me.
Sorry, just venting. I now own more of this stock than I thought I ever would.
i remember CLDA selling for 7 bucks and change and being very frustrated and impatient. Much how I feel right now. Watching FBN this morning, the big boys have TONS of cash Pfizer and company, I'll bet on RJ getting a cash offer for Pali.
I, too, own more of this stock than I ever thought I would and remain sanguine about its prospects. I do a present value of a successful Pali in Picasso and Matisse and 4 bucks for synthetics and a 30% premium on a deal. I add another 10% on the heavy short and squeeze, then add 3 bucks for the pr related to an Intrexon IPO. Okay, I KNOW why I'm in this heavy. The wait is killing me though. I never take the shorts seriously after CLDA. GLTA.